Top Markets
#1 QuantixAI QuantixAI +105.36%
#2 龙虾 (Lobster) 龙虾 (Lobster) +63.03%
#3 MetaDAO MetaDAO +28.63%
#4 Pons Pons +28.12%
#5 Rain Rain +23.09%
#6 Bedrock Bedrock +20.96%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +17.95%
#8 Ontology Gas Ontology Gas +17.34%
#9 Prom Prom +16.62%
#10 Humanity Humanity +14.86%
Coin of the day
QuantixAI QuantixAI
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Chemical Works Chemical Works

Chemical Works

RICHT
Classificação em ações #2662
Chemical Works of Gedeon Richter Plc engages in the development and manufacture... Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
Preço da ação
$41.81
Valor de mercado
$7.65B
Variação (1 dia)
0.23%
Variação (1 ano)
34.96%
País
HU
Negociar Chemical Works (RICHT)

Categoria

Healthcare
Lucros da Chemical Works (RICHT)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Chemical Works, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Chemical Works de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK